DESCRIPTION: Chronic pain originating from the musculoskelatal system is a
dominant cause of sick-leave in modem industry and can be a very disabling and
troublesome condition for the individual. Although the cause of this problem in
skeletal muscle is unknown, one of the most frequent situations in which muscle
pain is experienced is in industrial workers who have to move repeatedly and/or
forcibly. The cumulative trauma disorder (CTD) which results from repetitive
movements is of special interest because these repeat-motion injuries are one
of the most difficult to anticipate and prevent.
Our studies in humans have shown that exposure to a single bout of repeated
strains can lead to myofiber and fascial rupture without bleeding but
accompanied by muscle pain, restricted motion, and loss of strength and power.
Little is known about the effect of repeated strains on muscles or the dynamic
components of repeated use such as velocity and acceleration, which produce
injury resulting in CTD or CTD risk. Since variations in human exposure and
response together with the necessity for repeated tissue sampling makes man
unsuitable as a research subject, we have developed a rat model of repeated
strain injury (CTD).
Using this model, the present study is designed: (1) to produce muscle strain
injury in rats with and without fatigue using a custom-built dynamometer which
can result in pathologic fibers, (2) to measure TGF-beta and bradykinin in
response to muscle injury with and without pathology, (3) to assess the role of
TGF-beta in collagen production and 4) to assay for TGF-beta in the blood of
strain injured rats. Pathologic muscle fibers associated with TGF-beta will be
identified using immunohistochemical techniques. Collagen content will be
measured by HPLC. Active and latent forms of TGF-beta 1 and TGF-beta2 and type
I and III collagens will be quantified by Western blots.
Insight into the factors and conditions producing muscle injury with pathology
should provide a better understanding of the healing (adaptive) or
failed-healing (pathologic) processes of muscle and aid in the design of
preventative regimens for individuals in specific industrial settings.
National Institute for Occupational Safety and Health
CFDA Code
DUNS Number
191510239
UEI
M7PNRH24BBM8
Project Start Date
30-September-1995
Project End Date
31-May-2004
Budget Start Date
01-June-2001
Budget End Date
31-May-2002
Project Funding Information for 2001
Total Funding
$284,663
Direct Costs
$200,000
Indirect Costs
$84,663
Year
Funding IC
FY Total Cost by IC
2001
National Institute for Occupational Safety and Health
$284,663
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01OH002918-08A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01OH002918-08A2
Patents
No Patents information available for 2R01OH002918-08A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01OH002918-08A2
Clinical Studies
No Clinical Studies information available for 2R01OH002918-08A2
News and More
Related News Releases
No news release information available for 2R01OH002918-08A2
History
No Historical information available for 2R01OH002918-08A2
Similar Projects
No Similar Projects information available for 2R01OH002918-08A2